These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33277568)

  • 1. Discovery of a novel fibroblast activation protein (FAP) inhibitor, BR103354, with anti-diabetic and anti-steatotic effects.
    Cho JM; Yang EH; Quan W; Nam EH; Cheon HG
    Sci Rep; 2020 Dec; 10(1):21280. PubMed ID: 33277568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21.
    Dunshee DR; Bainbridge TW; Kljavin NM; Zavala-Solorio J; Schroeder AC; Chan R; Corpuz R; Wong M; Zhou W; Deshmukh G; Ly J; Sutherlin DP; Ernst JA; Sonoda J
    J Biol Chem; 2016 Mar; 291(11):5986-5996. PubMed ID: 26797127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast activation protein is dispensable for control of glucose homeostasis and body weight in mice.
    Panaro BL; Coppage AL; Beaudry JL; Varin EM; Kaur K; Lai JH; Wu W; Liu Y; Bachovchin WW; Drucker DJ
    Mol Metab; 2019 Jan; 19():65-74. PubMed ID: 30477988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity.
    Ryabtsova O; Jansen K; Van Goethem S; Joossens J; Cheng JD; Lambeir AM; De Meester I; Augustyns K; Van der Veken P
    Bioorg Med Chem Lett; 2012 May; 22(10):3412-7. PubMed ID: 22525314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys.
    Lee B; Shi L; Kassel DB; Asakawa T; Takeuchi K; Christopher RJ
    Eur J Pharmacol; 2008 Jul; 589(1-3):306-14. PubMed ID: 18538760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
    Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted 4-carboxymethylpyroglutamic acid diamides as potent and selective inhibitors of fibroblast activation protein.
    Tsai TY; Yeh TK; Chen X; Hsu T; Jao YC; Huang CH; Song JS; Huang YC; Chien CH; Chiu JH; Yen SC; Tang HK; Chao YS; Jiaang WT
    J Med Chem; 2010 Sep; 53(18):6572-83. PubMed ID: 20718420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAP finds FGF21 easy to digest.
    Gillum MP; Potthoff MJ
    Biochem J; 2016 May; 473(9):1125-7. PubMed ID: 27118870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current advances and therapeutic potential of agents targeting dipeptidyl peptidases-IV, -II, 8/9 and fibroblast activation protein.
    Chen SJ; Jiaang WT
    Curr Top Med Chem; 2011; 11(12):1447-63. PubMed ID: 21510839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitor-Decorated Polymer Conjugates Targeting Fibroblast Activation Protein.
    Dvořáková P; Bušek P; Knedlík T; Schimer J; Etrych T; Kostka L; Stollinová Šromová L; Šubr V; Šácha P; Šedo A; Konvalinka J
    J Med Chem; 2017 Oct; 60(20):8385-8393. PubMed ID: 28953383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of hypoglycemic, lipid-lowering and hepatoprotective effects of the Bixin and Bixin: β-CD inclusion compound in high-fat-fed obese mice.
    Pinzón-García AD; Orellano LAA; de Lazari MGT; Campos PP; Cortes ME; Sinisterra RD
    Biomed Pharmacother; 2018 Oct; 106():363-372. PubMed ID: 29966982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP).
    Jansen K; Heirbaut L; Verkerk R; Cheng JD; Joossens J; Cos P; Maes L; Lambeir AM; De Meester I; Augustyns K; Van der Veken P
    J Med Chem; 2014 Apr; 57(7):3053-74. PubMed ID: 24617858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human FGF-21 Is a Substrate of Fibroblast Activation Protein.
    Coppage AL; Heard KR; DiMare MT; Liu Y; Wu W; Lai JH; Bachovchin WW
    PLoS One; 2016; 11(3):e0151269. PubMed ID: 26962859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of ZYDPLA1, a novel long-acting dipeptidyl peptidase-4 inhibitor.
    Jain MR; Joharapurkar AA; Bahekar RH; Patel H; Jadav P; Kshirsagar SG; Patel VJ; Patel KN; Ramanathan VK; Patel PR; Desai RC
    J Diabetes; 2015 Sep; 7(5):708-17. PubMed ID: 25327540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase.
    Poplawski SE; Lai JH; Li Y; Jin Z; Liu Y; Wu W; Wu Y; Zhou Y; Sudmeier JL; Sanford DG; Bachovchin WW
    J Med Chem; 2013 May; 56(9):3467-77. PubMed ID: 23594271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of BR102910 as a selective fibroblast activation protein (FAP) inhibitor.
    Jung HJ; Nam EH; Park JY; Ghosh P; Kim IS
    Bioorg Med Chem Lett; 2021 Apr; 37():127846. PubMed ID: 33571650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-diabetic activities of Gegen Qinlian Decoction in high-fat diet combined with streptozotocin-induced diabetic rats and in 3T3-L1 adipocytes.
    Zhang CH; Xu GL; Liu YH; Rao Y; Yu RY; Zhang ZW; Wang YS; Tao L
    Phytomedicine; 2013 Feb; 20(3-4):221-9. PubMed ID: 23219338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of tumor growth in mice by rationally designed pseudopeptide inhibitors of fibroblast activation protein and prolyl oligopeptidase.
    Jackson KW; Christiansen VJ; Yadav VR; Silasi-Mansat R; Lupu F; Awasthi V; Zhang RR; McKee PA
    Neoplasia; 2015 Jan; 17(1):43-54. PubMed ID: 25622898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity.
    Edosada CY; Quan C; Wiesmann C; Tran T; Sutherlin D; Reynolds M; Elliott JM; Raab H; Fairbrother W; Wolf BB
    J Biol Chem; 2006 Mar; 281(11):7437-44. PubMed ID: 16410248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?
    Juillerat-Jeanneret L; Tafelmeyer P; Golshayan D
    Expert Opin Ther Targets; 2017 Oct; 21(10):977-991. PubMed ID: 28829211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.